Company profile
DEBN company profile
DEBN (Drug-Eluting Biopsy Needle) is a medical company developing a novel prostate biopsy needle for urologists which will reduce infectious complication rate. Prostate biopsy needle delivers the optimal antibiotic combination directly to the prostate, precisely at the place where potential infections start. This application method allows to use a more effective antibiotic which is not allowed for oral prophylaxis.
Business identity
- Website
- http://www.debn.eu/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2017-01-01, Year
Headquarters
- Headquarters
- Poraj, Silesia, Poland
- Postal code
- 80755
- Country code
- PL
- Continent
- Europe